RA Capital Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,175,038
| Closed | -$11.4M | – | 85 |
|
|
2022
Q3 | $11.4M | Hold |
6,175,038
| – | – | 0.24% | 57 |
|
|
2022
Q2 | $19M | Hold |
6,175,038
| – | – | 0.51% | 50 |
|
|
2022
Q1 | $44.6M | Buy |
6,175,038
+3,048,000
| +97% | +$22M | 0.97% | 32 |
|
|
2021
Q4 | $51.2M | Buy |
3,127,038
+2,127,038
| +213% | +$34.8M | 0.9% | 30 |
|
|
2021
Q3 | $9.95M | Hold |
1,000,000
| – | – | 0.14% | 76 |
|
|
2021
Q2 | $9.98M | Hold |
1,000,000
| – | – | 0.16% | 76 |
|
|
2021
Q1 | $9.96M | Buy |
+1,000,000
| New | +$9.96M | 0.15% | 71 |
|